Amryt Pharma plc (LON:AMYT – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 143 ($1.89) and traded as high as GBX 155 ($2.05). Amryt Pharma shares last traded at GBX 143 ($1.89), with a volume of 90,726 shares trading hands.
Amryt Pharma Stock Down 11.7 %
The stock’s 50-day moving average price is GBX 143 and its two-hundred day moving average price is GBX 143. The company has a current ratio of 1.80, a quick ratio of 1.14 and a debt-to-equity ratio of 66.05. The stock has a market capitalization of £457.11 million and a P/E ratio of -4.33.
About Amryt Pharma
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Further Reading
- Five stocks we like better than Amryt Pharma
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- How Much Can You Make in Stocks in One Month?
- P/E Ratio Calculation: How to Assess Stocks
- This Is the Top Large-Cap Stock Insiders Are Buying
- What is Put Option Volume?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
